Journal
TRENDS IN ENDOCRINOLOGY AND METABOLISM
Volume 30, Issue 2, Pages 132-143Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tem.2018.12.001
Keywords
-
Categories
Ask authors/readers for more resources
Metabolic syndrome and Alzheimer's disease (AD) are two major health issues in modern society causing an extraordinary financial burden for the global healthcare systems. A tight link between the pathologies of obesity and type 2 diabetes (T2D), and more recently between T2D and AD, has been discovered. Furthermore, in recent years it has become apparent that the circadian clock has an important function in controlling metabolism. This review integrates the role of the circadian clock in the development of these metabolic derangements and vice versa. Common features such as central insulin resistance, altered glycogen synthase kinase 3 beta (GSK3 beta) signalling, and central inflammation are discussed, and therapeutic interventions targeting those mechanisms are mentioned briefly.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available